Previous Close | 0.0610 |
Open | 0.0690 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0590 - 0.0690 |
52 Week Range | 0.0400 - 0.1730 |
Volume | |
Avg. Volume | 122,439 |
Market Cap | 17.816M |
Beta (5Y Monthly) | 1.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1420 |
Earnings Date | Mar 27, 2023 - Mar 31, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MEDIF
MediPharm Labs Corp. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO") today announced that MediPharm and VIVO have entered into a definitive arrangement agreement (the "Arrangement Agreement") whereby MediPharm has agreed to acquire VIVO in an all-equity business combination transaction (the "Transaction"). The Transaction is expected to combine two highly complementary businesses, creating a unique a